Introduction and objectives Short-term extreme increases in desert-derived particulate-matter with aerodynamic diameter below 10 μm (PM 10 ) may affect emergency department (ED) visits due to COPD exacerbations. Research question Our aim was to identify the effect of extreme increases in desert-derived PM 10 on ED visits for dyspnea and COPD exacerbations and on the related hospital admissions. Methods We performed a retrospective analysis of dyspnea-related ED visits and hospital admissions in Heraklion, Crete, during four consecutive storms of desert-derived PM 10 that happened during March 2018. We collected data from over 17,000 ED visits and recorded patients with atopic symptoms, COPD exacerbations, and dyspnea, as well as admissions to the departments of pulmonary medicine, internal medicine, and cardiology. PM 10 data were collected from a monitoring station in the same geographic area. Results Four desert dust storms were recorded during the study period with 238, 203, 1138, and 310 μg/m 3 average-daily PM 10 and 652, 308, 4262, and 778 μg/m 3 hourly mean day-peak PM 10, respectively. There was no clinically important increase in total ED visits, total admissions or admissions to the departments of cardiology, pulmonary medicine, or internal medicine, during PM 10 peaks. However, during the desert dust storm with daily-average PM 10 above 500 μg/m 3 , there was a striking increase in dyspnea-related ED visits (including COPD exacerbations, 3.6-fold increase), while there was no clinically important increase in non-asthma allergy-related ED visits. Conclusion Extreme desert dust storm episodes may cause meaningful increases in ED visits for dyspnea and COPD exacerbations/admissions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.